These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
969 related articles for article (PubMed ID: 19644956)
1. Characterization of LMX-1A as a metastasis suppressor in cervical cancer. Liu CY; Chao TK; Su PH; Lee HY; Shih YL; Su HY; Chu TY; Yu MH; Lin YW; Lai HC J Pathol; 2009 Oct; 219(2):222-31. PubMed ID: 19644956 [TBL] [Abstract][Full Text] [Related]
2. SFRP1 and SFRP2 suppress the transformation and invasion abilities of cervical cancer cells through Wnt signal pathway. Chung MT; Lai HC; Sytwu HK; Yan MD; Shih YL; Chang CC; Yu MH; Liu HS; Chu DW; Lin YW Gynecol Oncol; 2009 Mar; 112(3):646-53. PubMed ID: 19095296 [TBL] [Abstract][Full Text] [Related]
3. [Inhibitory effect of bladder cancer related protein gene on HeLa cell proliferation]. Zuo ZH; Zhao M; Liu J; Wei Y; Wu XX Ai Zheng; 2006 Jul; 25(7):811-7. PubMed ID: 16831269 [TBL] [Abstract][Full Text] [Related]
4. Insulin-like growth factor 1 is a potent stimulator of cervical cancer cell invasiveness and proliferation that is modulated by alphavbeta3 integrin signaling. Shen MR; Hsu YM; Hsu KF; Chen YF; Tang MJ; Chou CY Carcinogenesis; 2006 May; 27(5):962-71. PubMed ID: 16400188 [TBL] [Abstract][Full Text] [Related]
5. Overexpression of LAMP3/TSC403/DC-LAMP promotes metastasis in uterine cervical cancer. Kanao H; Enomoto T; Kimura T; Fujita M; Nakashima R; Ueda Y; Ueno Y; Miyatake T; Yoshizaki T; Buzard GS; Tanigami A; Yoshino K; Murata Y Cancer Res; 2005 Oct; 65(19):8640-5. PubMed ID: 16204031 [TBL] [Abstract][Full Text] [Related]
6. Four-and-a-half LIM protein 2 promotes invasive potential and epithelial-mesenchymal transition in colon cancer. Zhang W; Jiang B; Guo Z; Sardet C; Zou B; Lam CS; Li J; He M; Lan HY; Pang R; Hung IF; Tan VP; Wang J; Wong BC Carcinogenesis; 2010 Jul; 31(7):1220-9. PubMed ID: 20460358 [TBL] [Abstract][Full Text] [Related]
7. Development and assessment of a general theory of cervical carcinogenesis utilizing a severe combined immunodeficiency murine-human xenograft model. Tewari KS; Taylor JA; Liao SY; DiSaia PJ; Burger RA; Monk BJ; Hughes CC; Villarreal LP Gynecol Oncol; 2000 Apr; 77(1):137-48. PubMed ID: 10739703 [TBL] [Abstract][Full Text] [Related]
8. Stromelysin-3 over-expression enhances tumourigenesis in MCF-7 and MDA-MB-231 breast cancer cell lines: involvement of the IGF-1 signalling pathway. Kasper G; Reule M; Tschirschmann M; Dankert N; Stout-Weider K; Lauster R; Schrock E; Mennerich D; Duda GN; Lehmann KE BMC Cancer; 2007 Jan; 7():12. PubMed ID: 17233884 [TBL] [Abstract][Full Text] [Related]
9. Aberrant promoter methylation and silencing of the POU2F3 gene in cervical cancer. Zhang Z; Huettner PC; Nguyen L; Bidder M; Funk MC; Li J; Rader JS Oncogene; 2006 Aug; 25(39):5436-45. PubMed ID: 16607278 [TBL] [Abstract][Full Text] [Related]
10. Bone morphogenetic protein 7 in the development and treatment of bone metastases from breast cancer. Buijs JT; Henriquez NV; van Overveld PG; van der Horst G; Que I; Schwaninger R; Rentsch C; Ten Dijke P; Cleton-Jansen AM; Driouch K; Lidereau R; Bachelier R; Vukicevic S; Clézardin P; Papapoulos SE; Cecchini MG; Löwik CW; van der Pluijm G Cancer Res; 2007 Sep; 67(18):8742-51. PubMed ID: 17875715 [TBL] [Abstract][Full Text] [Related]
11. A tumor-protective role for human kallikrein-related peptidase 6 in breast cancer mediated by inhibition of epithelial-to-mesenchymal transition. Pampalakis G; Prosnikli E; Agalioti T; Vlahou A; Zoumpourlis V; Sotiropoulou G Cancer Res; 2009 May; 69(9):3779-87. PubMed ID: 19383923 [TBL] [Abstract][Full Text] [Related]
12. [Epithelial-mesenchymal transition in cancer progression]. Gos M; Miłoszewska J; Przybyszewska M Postepy Biochem; 2009; 55(2):121-8. PubMed ID: 19824467 [TBL] [Abstract][Full Text] [Related]
13. Suppression of FHL2 expression induces cell differentiation and inhibits gastric and colon carcinogenesis. Wang J; Yang Y; Xia HH; Gu Q; Lin MC; Jiang B; Peng Y; Li G; An X; Zhang Y; Zhuang Z; Zhang Z; Kung HF; Wong BC Gastroenterology; 2007 Mar; 132(3):1066-76. PubMed ID: 17383428 [TBL] [Abstract][Full Text] [Related]
14. Targeting focal adhesion kinase with dominant-negative FRNK or Hsp90 inhibitor 17-DMAG suppresses tumor growth and metastasis of SiHa cervical xenografts. Schwock J; Dhani N; Cao MP; Zheng J; Clarkson R; Radulovich N; Navab R; Horn LC; Hedley DW Cancer Res; 2009 Jun; 69(11):4750-9. PubMed ID: 19458065 [TBL] [Abstract][Full Text] [Related]
15. Expression profiling of epithelial plasticity in tumor progression. Jechlinger M; Grunert S; Tamir IH; Janda E; Lüdemann S; Waerner T; Seither P; Weith A; Beug H; Kraut N Oncogene; 2003 Oct; 22(46):7155-69. PubMed ID: 14562044 [TBL] [Abstract][Full Text] [Related]
16. Small interfering RNA-mediated down-regulation of SPAG9 inhibits cervical tumor growth. Garg M; Kanojia D; Suri S; Suri A Cancer; 2009 Dec; 115(24):5688-99. PubMed ID: 19813278 [TBL] [Abstract][Full Text] [Related]
17. Germ cell-specific heat shock protein 70-2 is expressed in cervical carcinoma and is involved in the growth, migration, and invasion of cervical cells. Garg M; Kanojia D; Saini S; Suri S; Gupta A; Surolia A; Suri A Cancer; 2010 Aug; 116(16):3785-96. PubMed ID: 20564126 [TBL] [Abstract][Full Text] [Related]
18. Synuclein-gamma is closely involved in perineural invasion and distant metastasis in mouse models and is a novel prognostic factor in pancreatic cancer. Hibi T; Mori T; Fukuma M; Yamazaki K; Hashiguchi A; Yamada T; Tanabe M; Aiura K; Kawakami T; Ogiwara A; Kosuge T; Kitajima M; Kitagawa Y; Sakamoto M Clin Cancer Res; 2009 Apr; 15(8):2864-71. PubMed ID: 19351749 [TBL] [Abstract][Full Text] [Related]
19. Mesenchymal-to-epithelial transition facilitates bladder cancer metastasis: role of fibroblast growth factor receptor-2. Chaffer CL; Brennan JP; Slavin JL; Blick T; Thompson EW; Williams ED Cancer Res; 2006 Dec; 66(23):11271-8. PubMed ID: 17145872 [TBL] [Abstract][Full Text] [Related]
20. Expression of the serum response factor in hepatocellular carcinoma: implications for epithelial-mesenchymal transition. Park MY; Kim KR; Park HS; Park BH; Choi HN; Jang KY; Chung MJ; Kang MJ; Lee DG; Moon WS Int J Oncol; 2007 Dec; 31(6):1309-15. PubMed ID: 17982656 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]